🚀 VC round data is live in beta, check it out!
Sopharma Trading Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sopharma Trading and similar public comparables like Ubcare, Medika, Kewaunee Scientific, Quipt Home Medical and more.
Sopharma Trading Overview
About Sopharma Trading
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
Founded
1998
HQ
Employees
1.5K
Website
Sectors
Financials (LTM)
EV
$351M
Sopharma Trading Financials
Sopharma Trading reported last 12-month revenue of $1B and EBITDA of $77M.
In the same LTM period, Sopharma Trading generated $77M in EBITDA and $37M in net income.
Revenue (LTM)
Sopharma Trading P&L
In the most recent fiscal year, Sopharma Trading reported revenue of $1B and EBITDA of $57M.
Sopharma Trading expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $145M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $77M | XXX | $57M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $37M | XXX | $24M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $106M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sopharma Trading Stock Performance
Sopharma Trading has current market cap of $138M, and enterprise value of $351M.
Market Cap Evolution
Sopharma Trading's stock price is $4.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $351M | $138M | 0.3% | XXX | XXX | XXX | $0.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSopharma Trading Valuation Multiples
Sopharma Trading trades at 0.3x EV/Revenue multiple, and 4.6x EV/EBITDA.
EV / Revenue (LTM)
Sopharma Trading Financial Valuation Multiples
As of April 8, 2026, Sopharma Trading has market cap of $138M and EV of $351M.
Equity research analysts estimate Sopharma Trading's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sopharma Trading has a P/E ratio of 3.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $138M | XXX | $138M | XXX | XXX | XXX |
| EV (current) | $351M | XXX | $351M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBIT | 7.0x | XXX | 9.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.4x | XXX | XXX | XXX |
| P/E | 3.7x | XXX | 5.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 11.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sopharma Trading Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sopharma Trading Margins & Growth Rates
Sopharma Trading's revenue in the last 12 month grew by 4%.
Sopharma Trading's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.1M for the same period.
Sopharma Trading's rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sopharma Trading's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sopharma Trading Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | 36% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 11% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Trading Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ubcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Medika | XXX | XXX | XXX | XXX | XXX | XXX |
| Kewaunee Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Quipt Home Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| ADDvise Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sopharma Trading M&A Activity
Sopharma Trading acquired XXX companies to date.
Last acquisition by Sopharma Trading was on XXXXXXXX, XXXXX. Sopharma Trading acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sopharma Trading
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSopharma Trading Investment Activity
Sopharma Trading invested in XXX companies to date.
Sopharma Trading made its latest investment on XXXXXXXX, XXXXX. Sopharma Trading invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sopharma Trading
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sopharma Trading
| When was Sopharma Trading founded? | Sopharma Trading was founded in 1998. |
| Where is Sopharma Trading headquartered? | Sopharma Trading is headquartered in Bulgaria. |
| How many employees does Sopharma Trading have? | As of today, Sopharma Trading has over 1K employees. |
| Is Sopharma Trading publicly listed? | Yes, Sopharma Trading is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Sopharma Trading? | Sopharma Trading trades under SFT ticker. |
| When did Sopharma Trading go public? | Sopharma Trading went public in 2008. |
| Who are competitors of Sopharma Trading? | Sopharma Trading main competitors are Ubcare, Medika, Kewaunee Scientific, Quipt Home Medical. |
| What is the current market cap of Sopharma Trading? | Sopharma Trading's current market cap is $138M. |
| What is the current revenue of Sopharma Trading? | Sopharma Trading's last 12 months revenue is $1B. |
| What is the current revenue growth of Sopharma Trading? | Sopharma Trading revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Sopharma Trading? | Current revenue multiple of Sopharma Trading is 0.3x. |
| Is Sopharma Trading profitable? | Yes, Sopharma Trading is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sopharma Trading? | Sopharma Trading's last 12 months EBITDA is $77M. |
| What is Sopharma Trading's EBITDA margin? | Sopharma Trading's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of Sopharma Trading? | Current EBITDA multiple of Sopharma Trading is 4.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.